Unravelling the complexity of cancer-immune system interplay

Cara K. Fraser, Michael P. Brown, Kerrilyn R. Diener, John D. Hayball

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

The immune system has an intricate and complex relationship with tumorigenesis; while it has the capacity to identify and eliminate cancerous cells, the emergence of a tumor signifies its failure to do this. Thus, the immune-tumor interplay is paradoxical as through initial suppression of tumor growth, an immunologically silent or even suppressive tumor evolves. Furthermore, certain immune processes, such as chronic inflammation and immunosuppression, can facilitate malignant progression. Nevertheless, immunotherapeutic approaches can manipulate the immune milieu to improve the therapeutic outcomes of cancer treatments. Furthermore, particular conventional cancer therapies also have immunostimulatory properties in their own right. An in-depth understanding of the intimate involvement of the immune system in tumorigenesis and the potential to manipulate this interaction to improve disease outcomes will enable the development of new and broadly effective cancer therapies.

LanguageEnglish
Pages917-934
Number of pages18
JournalExpert Review of Anticancer Therapy
Volume10
Issue number6
DOIs
Publication statusPublished - 1 Jun 2010

Keywords

  • Chemotherapy
  • Immunosuppression
  • Inflammation
  • Monoclonal antibody
  • Tumor immunology
  • Tumor immunotherapy

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this

Fraser, C. K., Brown, M. P., Diener, K. R., & Hayball, J. D. (2010). Unravelling the complexity of cancer-immune system interplay. Expert Review of Anticancer Therapy, 10(6), 917-934. https://doi.org/10.1586/era.10.66
Fraser, Cara K. ; Brown, Michael P. ; Diener, Kerrilyn R. ; Hayball, John D. / Unravelling the complexity of cancer-immune system interplay. In: Expert Review of Anticancer Therapy. 2010 ; Vol. 10, No. 6. pp. 917-934.
@article{c1f0552323674d39b82631f55a758400,
title = "Unravelling the complexity of cancer-immune system interplay",
abstract = "The immune system has an intricate and complex relationship with tumorigenesis; while it has the capacity to identify and eliminate cancerous cells, the emergence of a tumor signifies its failure to do this. Thus, the immune-tumor interplay is paradoxical as through initial suppression of tumor growth, an immunologically silent or even suppressive tumor evolves. Furthermore, certain immune processes, such as chronic inflammation and immunosuppression, can facilitate malignant progression. Nevertheless, immunotherapeutic approaches can manipulate the immune milieu to improve the therapeutic outcomes of cancer treatments. Furthermore, particular conventional cancer therapies also have immunostimulatory properties in their own right. An in-depth understanding of the intimate involvement of the immune system in tumorigenesis and the potential to manipulate this interaction to improve disease outcomes will enable the development of new and broadly effective cancer therapies.",
keywords = "Chemotherapy, Immunosuppression, Inflammation, Monoclonal antibody, Tumor immunology, Tumor immunotherapy",
author = "Fraser, {Cara K.} and Brown, {Michael P.} and Diener, {Kerrilyn R.} and Hayball, {John D.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1586/era.10.66",
language = "English",
volume = "10",
pages = "917--934",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "6",

}

Fraser, CK, Brown, MP, Diener, KR & Hayball, JD 2010, 'Unravelling the complexity of cancer-immune system interplay', Expert Review of Anticancer Therapy, vol. 10, no. 6, pp. 917-934. https://doi.org/10.1586/era.10.66

Unravelling the complexity of cancer-immune system interplay. / Fraser, Cara K.; Brown, Michael P.; Diener, Kerrilyn R.; Hayball, John D.

In: Expert Review of Anticancer Therapy, Vol. 10, No. 6, 01.06.2010, p. 917-934.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Unravelling the complexity of cancer-immune system interplay

AU - Fraser, Cara K.

AU - Brown, Michael P.

AU - Diener, Kerrilyn R.

AU - Hayball, John D.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - The immune system has an intricate and complex relationship with tumorigenesis; while it has the capacity to identify and eliminate cancerous cells, the emergence of a tumor signifies its failure to do this. Thus, the immune-tumor interplay is paradoxical as through initial suppression of tumor growth, an immunologically silent or even suppressive tumor evolves. Furthermore, certain immune processes, such as chronic inflammation and immunosuppression, can facilitate malignant progression. Nevertheless, immunotherapeutic approaches can manipulate the immune milieu to improve the therapeutic outcomes of cancer treatments. Furthermore, particular conventional cancer therapies also have immunostimulatory properties in their own right. An in-depth understanding of the intimate involvement of the immune system in tumorigenesis and the potential to manipulate this interaction to improve disease outcomes will enable the development of new and broadly effective cancer therapies.

AB - The immune system has an intricate and complex relationship with tumorigenesis; while it has the capacity to identify and eliminate cancerous cells, the emergence of a tumor signifies its failure to do this. Thus, the immune-tumor interplay is paradoxical as through initial suppression of tumor growth, an immunologically silent or even suppressive tumor evolves. Furthermore, certain immune processes, such as chronic inflammation and immunosuppression, can facilitate malignant progression. Nevertheless, immunotherapeutic approaches can manipulate the immune milieu to improve the therapeutic outcomes of cancer treatments. Furthermore, particular conventional cancer therapies also have immunostimulatory properties in their own right. An in-depth understanding of the intimate involvement of the immune system in tumorigenesis and the potential to manipulate this interaction to improve disease outcomes will enable the development of new and broadly effective cancer therapies.

KW - Chemotherapy

KW - Immunosuppression

KW - Inflammation

KW - Monoclonal antibody

KW - Tumor immunology

KW - Tumor immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=77953762879&partnerID=8YFLogxK

U2 - 10.1586/era.10.66

DO - 10.1586/era.10.66

M3 - Review article

VL - 10

SP - 917

EP - 934

JO - Expert Review of Anticancer Therapy

T2 - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 6

ER -